Int J Audiol:慢性鼻窦炎患者中存在隐性听力损失么?

2019-09-26 AlexYang MedSci原创

最近,有研究人员调查了是否在慢性鼻窦炎(CRS)中听觉功能具有损伤。研究总共包括了85名患者,并分配到CRS组(n=65)或者单纯鼻中隔偏曲组(n=20)。两个小组均没有感觉神经性耳聋的其他风险因子,并表现出了正常的听觉阈值。研究还包括了没有CRS或者单纯鼻中隔偏曲的对照组(n=30),并且性别和年龄上与患者组匹配。研究人员进行了听觉测试分析,包括了纯音听觉、声阻抗测试、畸变产物耳声发射(DPOA

最近,有研究人员调查了是否在慢性鼻窦炎(CRS)中听觉功能具有损伤。

研究总共包括了85名患者,并分配到CRS组(n=65)或者单纯鼻中隔偏曲组(n=20)。两个小组均没有感觉神经性耳聋的其他风险因子,并表现出了正常的听觉阈值。研究还包括了没有CRS或者单纯鼻中隔偏曲的对照组(n=30),并且性别和年龄上与患者组匹配。研究人员进行了听觉测试分析,包括了纯音听觉、声阻抗测试、畸变产物耳声发射(DPOAE)和听觉脑干响应(ABR)。研究发现,在每个高频纯音听觉下,组间差异均达到了显著差异(p<0.05)。CRS的DPOAE通过比例要比对照组更低。

最后,研究人员指出,他们的研究表明了CRS与听觉损伤之间存在显著的联系。CRS可能通过损伤内耳毛细胞、外耳毛细胞(OHCs)来损伤耳蜗功能,最终导致整个听觉的改变。

原始出处:

Lin S, Lin X, Ye S et al. Is there "hidden hearing loss" in patients with chronic rhinosinusitis?Int J Audiol. 14 Sep 2019

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=373328, encodeId=1eb03e33287a, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Sep 29 05:05:43 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373283, encodeId=c6d13e32832d, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sat Sep 28 05:39:11 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306428, encodeId=01b6130642839, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Sep 28 05:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351404, encodeId=675c135140412, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Sep 28 05:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=)]
    2019-09-29 yjs木玉

    好好好好好好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=373328, encodeId=1eb03e33287a, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Sep 29 05:05:43 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373283, encodeId=c6d13e32832d, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sat Sep 28 05:39:11 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306428, encodeId=01b6130642839, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Sep 28 05:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351404, encodeId=675c135140412, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Sep 28 05:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=)]
    2019-09-28 深海的鱼

    学习学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=373328, encodeId=1eb03e33287a, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Sep 29 05:05:43 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373283, encodeId=c6d13e32832d, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sat Sep 28 05:39:11 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306428, encodeId=01b6130642839, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Sep 28 05:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351404, encodeId=675c135140412, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Sep 28 05:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=)]
    2019-09-28 ysjykql
  4. [GetPortalCommentsPageByObjectIdResponse(id=373328, encodeId=1eb03e33287a, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Sun Sep 29 05:05:43 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373283, encodeId=c6d13e32832d, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sat Sep 28 05:39:11 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306428, encodeId=01b6130642839, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Sep 28 05:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351404, encodeId=675c135140412, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Sep 28 05:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=)]

相关资讯

Int Forum Allergy Rhinol:囊性纤维化慢性鼻窦炎的严重度临床预测因子研究

慢性鼻窦炎(CRS)是一种囊性纤维化(CF)的显著表现,并且症状广泛,疾病严重度也不一。最近,有研究人员确定了与疾病严重度结果相关的一些临床变量.研究包括了33名CF-CRS患者,平均跟踪调查的时间为15个月。在研究期间,鼻炎发作患者比例为61%,并且女性患者恶化的风险增加。二次就诊时,肺部恶化与窦性恶化的让步比为2.07。另外,CF相关的糖尿病与更差的症状和内窥镜情况相关。金黄色葡萄球菌感染能够

Am J Rhinol Allergy:基于哮喘和过敏性鼻炎并发的慢性鼻窦炎表型的组织病理学内皮分型分析

根据表型和内皮分型,临床研究中越来越倾向于改善慢性鼻窦炎(CRS)的特性。最近,有研究人员利用组织病理学标记对支气管哮喘(BA)和过敏性鼻炎并发或有或无情况下的CRS表型进行了鉴定。研究是一个前瞻性的案例对照研究,包括了82名参与者。其中67名为CRS患者,15名为对照。研究发现,在具有AR或BA以及均有的CRS患者中,与对照组相比,嗜酸性粒细胞的比例显著增加(p<0.001)。相反,不具有

FDA批准了优先审查赛诺菲的白细胞介素-4单抗Dupixent治疗鼻窦炎

Dupilumab是一种完全人源性抗白细胞介素-4受体α单克隆抗体,可阻断白细胞介素-4和白细胞介素-13的信号传导,可以减轻2型炎症。该药物获得优先审查是基于两项关键性III期试验数据的支持,这些试验评估了Dupixent与标准治疗药物皮质类固醇鼻喷雾剂联合使用时的疗效和安全性。

中间型链球菌感染性鼻窦炎导致急性硬膜下脓肿1’例

男,13岁。因发热、头痛伴呕吐3d入院。入院3d前因发热、头痛于本院儿科就诊,考虑呼吸道感染予以对症治疗后,症状无缓解且出现恶心呕吐,再次就诊。行头部CT扫描(图1A、1B)提示右侧额颞顶硬膜下积液,颅内积气,环池及右侧脑室受压,中线结构轻度移位,副鼻窦炎。既往慢性鼻窦炎病史5年,无头部外伤史,入院查体无明显神经系统阳性体征。

Allergy:Dupilumab能够改善慢性鼻窦炎鼻息肉患者的生活质量

鼻息肉慢性鼻窦炎(CRSwNP)能够对健康相关的生活质量(HRQoL)造成负面影响。在一个之前报道的随机临床试验中(NCT01920893),额外添加Dupilumab到糠酸莫米他松中能够显著的改善对鼻内皮质类固醇抗性(INCS)CRSwNP患者的内镜、放射学和临床终点及病人报告的结果。最近,有研究人员调查了Dupilumab治疗对HRQoL和治疗效果的影响。研究发现,经过16周的治疗,患有中度到